Next Article in Journal
Building a Biopsychosocial Conceptual Framework to Explore Pressure Ulcer Pain for Hospitalized Patients
Next Article in Special Issue
Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing
Previous Article in Journal
Identification of Predictors for Weight Reduction in Children and Adolescents with Overweight and Obesity (IDA-Insel Survey)
Previous Article in Special Issue
Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis
Article Menu

Export Article

Open AccessReview
Healthcare 2016, 4(1), 6; doi:10.3390/healthcare4010006

Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic Medicine

1
College of Public Health, Department of Global Health, University of South Florida, Tampa, FL 33620, USA
2
Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA
*
Author to whom correspondence should be addressed.
Academic Editors: Cecelia A. Bellcross and Debra Duquette
Received: 30 August 2015 / Revised: 17 December 2015 / Accepted: 6 January 2016 / Published: 8 January 2016
(This article belongs to the Special Issue Implementation of Public Health Genomics)
View Full-Text   |   Download PDF [842 KB, uploaded 8 January 2016]   |  

Abstract

This article introduces the identification, prevention, and treatment of hereditary cancer as an important public health concern. Hereditary cancer research and educational outreach activities are used to illustrate how public health functions can help to achieve health benefits of genetic and genomic medicine. First, we evaluate genetic service delivery through triangulating patient and provider survey results which reveal variability among providers in hereditary cancer knowledge and genetic service provision. Second, we describe efforts we have made to assure competency among healthcare providers and to inform, educate and empower patients with regard to the rapidly evolving field of genomics and hereditary cancer. Lastly, key policy-issues raised by our experiences are discussed in the context of how they may help us to more effectively translate future genomic technologies into practice in order to attain population health benefits from genetic and genomic medicine. View Full-Text
Keywords: genetic testing; hereditary breast and ovarian cancer syndrome; genomics; public health genetic testing; hereditary breast and ovarian cancer syndrome; genomics; public health
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Cragun, D.; Lewis, C.; Camperlengo, L.; Pal, T. Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic Medicine. Healthcare 2016, 4, 6.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Healthcare EISSN 2227-9032 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top